|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dimou A and Papadimitrakopoulou V:
Non-small cell lung cancer beyond biomarkers: The evolving
landscape of clinical trial design. J Pers Med. 4:386–401. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chouaid C, Crequit P, Borget I and
Vergnenegre A: Economic evaluation of first-line and maintenance
treatments for advanced non-small cell lung cancer: A systematic
review. Clinicoecon Outcomes Res. 7:9–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Landi L and Cappuzzo F: Pharmacotherapy
targeting the EGFR oncogene in NSCLC. Expert Opin Pharmacother.
15:2293–2305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Domvri K, Zarogoulidis P, Darwiche K,
Browning RF, Li Q, Turner JF, Kioumis I, Spyratos D, Porpodis K,
Papaiwannou A, et al: Molecular targeted drugs and biomarkers in
NSCLC, the evolving role of individualized therapy. J Cancer.
4:736–754. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Song Y, Wang Y, Luo J and Yu W:
MicroRNA-148a suppresses epithelial-to-mesenchymal transition by
targeting ROCK1 in non-small cell lung cancer cells. Mol Cell
Biochem. 380:277–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang M, Zhang P, Hu G, Xiao Z, Xu F,
Zhong T, Huang F, Kuang H and Zhang W: Relative expressions of
miR-205-5p, miR-205-3p and miR-21 in tissues and serum of non-small
cell lung cancer patients. Mol Cell Biochem. 383:67–75. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu L, Shao X, Gao W, Zhang Z, Liu P, Wang
R, Huang P, Yin Y and Shu Y: MicroRNA-133b inhibits the growth of
non-small-cell lung cancer by targeting the epidermal growth factor
receptor. FEBS J. 279:3800–3812. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng K, Liu W, Liu Y, Jiang C and Qian Q:
MicroRNA-133a suppresses colorectal cancer cell invasion by
targeting Fascin1. Oncol Lett. 9:869–874. 2015.PubMed/NCBI
|
|
11
|
Zhao J, Zhou Y, Zhang Z, Tian F, Ma N, Liu
T, Gu Z and Wang Y: Upregulated fascin1 in non-small cell lung
cancer promotes the migration and invasiveness, but not
proliferation. Cancer Lett. 290:238–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boon RA and Vickers KC: Intercellular
transport of microRNAs. Arterioscler Thromb Vasc Biol. 33:186–192.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Yan S, Pei C and Cui Y: Decreased
microRNA-132 and its function in human non-small cell lung cancer.
Mol Med Rep. 11:3601–3608. 2015.PubMed/NCBI
|
|
15
|
Liu MX, Zhou KC and Cao Y: MCRS1
overexpression, which is specifically inhibited by miR-129*,
promotes the epithelial-mesenchymal transition and metastasis in
non-small cell lung cancer. Mol Cancer. 13:2452014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Campayo M, Navarro A, Vinolas N, Diaz T,
Tejero R, Gimferrer JM, Molins L, Cabanas ML, Ramirez J, Monzo M
and Marrades R: Low miR-145 and high miR-367 are associated with
unfavourable prognosis in resected nonsmall cell lung cancer. Eur
Respir J. 41:1172–1178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng
A and Hu J: MiRNA-145 inhibits non-small cell lung cancer cell
proliferation by targeting c-Myc. J Exp Clin Cancer Res.
29:1512010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Crawford M, Batte K, Yu L, Wu X, Nuovo GJ,
Marsh CB, Otterson GA and Nana-Sinkam SP: MicroRNA 133B targets
pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem
Biophys Res Commun. 388:483–489. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen XN, Wang KF, Xu ZQ, Li SJ, Liu Q, Fu
DH, Wang X and Wu B: MiR-133b regulates bladder cancer cell
proliferation and apoptosis by targeting Bcl-w and Akt1. Cancer
Cell Int. 14:702014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Li Y and Jiang C: MiR-133b
contributes to arsenic-induced apoptosis in U251 glioma cells by
targeting the hERG channel. J Mol Neurosci. 55:985–994. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu Y, Crawford M, Yu B, Mao Y, Nana-Sinkam
SP and Lee LJ: MicroRNA delivery by cationic lipoplexes for lung
cancer therapy. Mol Pharm. 8:1381–1389. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park SH, Song JY, Kim YK, Heo JH, Kang H,
Kim G, An HJ and Kim TH: Fascin1 expression in high-grade serous
ovarian carcinoma is a prognostic marker and knockdown of fascin1
suppresses the proliferation of ovarian cancer cells. Int J Oncol.
44:637–646. 2014.PubMed/NCBI
|
|
23
|
Guo L, Bai H, Zou D, Hong T, Liu J, Huang
J, He P, Zhou Q and He J: The role of microRNA-133b and its target
gene FSCN1 in gastric cancer. J Exp Clin Cancer Res. 33:992014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hwang JH, Smith CA, Salhia B and Rutka JT:
The role of fascin in the migration and invasiveness of malignant
glioma cells. Neoplasia. 10:149–159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Al-Alwan M, Olabi S, Ghebeh H, Barhoush E,
Tulbah A, Al-Tweigeri T, Ajarim D and Adra C: Fascin is a key
regulator of breast cancer invasion that acts via the modification
of metastasis-associated molecules. PLoS One. 6:e273392011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and
Matsubara H: MiR-145, miR-133a and miR-133b: Tumor-suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamamoto H, Kohashi K, Fujita A and Oda Y:
Fascin-1 overexpression and miR-133b downregulation in the
progression of gastrointestinal stromal tumor. Mod Pathol.
26:563–571. 2013. View Article : Google Scholar : PubMed/NCBI
|
